Literature DB >> 33075296

Home monitoring for patients with ILD and the COVID-19 pandemic.

G Nakshbandi1, C C Moor1, M S Wijsenbeek2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33075296      PMCID： PMC7567485          DOI： 10.1016/S2213-2600(20)30452-5

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  8 in total

1.  Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.

Authors:  Catharina C Moor; Rémy L M Mostard; Jan C Grutters; Paul Bresser; Joachim G J V Aerts; Niels H Chavannes; Marlies S Wijsenbeek
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

Review 2.  Spectrum of Fibrotic Lung Diseases.

Authors:  Marlies Wijsenbeek; Vincent Cottin
Journal:  N Engl J Med       Date:  2020-09-03       Impact factor: 91.245

3.  Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.

Authors:  Toby M Maher; Tamera J Corte; Aryeh Fischer; Michael Kreuter; David J Lederer; Maria Molina-Molina; Judit Axmann; Klaus-Uwe Kirchgaessler; Katerina Samara; Frank Gilberg; Vincent Cottin
Journal:  Lancet Respir Med       Date:  2019-09-29       Impact factor: 30.700

4.  Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.

Authors:  Anne-Marie Russell; Huzaifa Adamali; Philip L Molyneaux; Pauline T Lukey; Richard P Marshall; Elisabetta A Renzoni; Athol U Wells; Toby M Maher
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 30.528

5.  A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.

Authors:  C C Moor; M Wapenaar; J R Miedema; J J M Geelhoed; P P Chandoesing; M S Wijsenbeek
Journal:  Respir Res       Date:  2018-05-29

6.  Remote Monitoring in Idiopathic Pulmonary Fibrosis: Home Is Where the Bluetooth-enabled Spirometer Is.

Authors:  Kerri A Johannson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

7.  Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study.

Authors:  Marlies Wijsenbeek; Elisabeth Bendstrup; Claudia Valenzuela; Michael T Henry; Catharina Moor; Monica Bengus; Andras Perjesi; Frank Gilberg; Klaus-Uwe Kirchgaessler; Carlo Vancheri
Journal:  Adv Ther       Date:  2018-11-30       Impact factor: 3.845

Review 8.  Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic.

Authors:  Alyson W Wong; Lee Fidler; Veronica Marcoux; Kerri A Johannson; Deborah Assayag; Jolene H Fisher; Nathan Hambly; Martin Kolb; Julie Morisset; Shane Shapera; Christopher J Ryerson
Journal:  Chest       Date:  2020-04-22       Impact factor: 9.410
  8 in total
  7 in total

1.  Pulmonary Fibrosis in the Time of COVID-19.

Authors:  Ivette Buendia-Roldan; Claudia Valenzuela; Moisés Selman
Journal:  Arch Bronconeumol       Date:  2022-04-15       Impact factor: 6.333

Review 2.  Educational aspects of rare and orphan lung diseases.

Authors:  Tiago M Alfaro; Marlies S Wijsenbeek; Pippa Powell; Daiana Stolz; John R Hurst; Michael Kreuter; Catharina C Moor
Journal:  Respir Res       Date:  2021-03-24

3.  An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: Development and preliminary application.

Authors:  Leonardo Pereira Motta; Pedro Paulo Ferreira da Silva; Bruno Max Borguezan; Jorge Luis Machado do Amaral; Lucimar Gonçalves Milagres; Márcio Neves Bóia; Marcos Rochedo Ferraz; Roberto Mogami; Rodolfo Acatauassú Nunes; Pedro Lopes de Melo
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

4.  Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians.

Authors:  Malik Althobiani; Jaber S Alqahtani; John R Hurst; Anne-Marie Russell; Joanna Porter
Journal:  BMJ Open Respir Res       Date:  2021-12

Review 5.  Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review.

Authors:  Malik A Althobiani; Rebecca A Evans; Jaber S Alqahtani; Abdulelah M Aldhahir; Anne-Marie Russell; John R Hurst; Joanna C Porter
Journal:  ERJ Open Res       Date:  2021-12-20

6.  Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and Usability.

Authors:  Ajay Sheshadri; Sukh Makhnoon; Amin M Alousi; Lara Bashoura; Rene Andrade; Christopher J Miller; Karen R Stolar; Muhammad Hasan Arain; Laila Noor; Amulya Balagani; Akash Jain; David Blanco; Abel Ortiz; Michael S Taylor; Alex Stenzler; Rohtesh Mehta; Uday R Popat; Chitra Hosing; David E Ost; Richard E Champlin; Burton F Dickey; Susan K Peterson
Journal:  JMIR Form Res       Date:  2022-02-07

7.  Home monitoring of lung function, symptoms and quality of life after admission with COVID-19 infection: The HOMECOMIN' study.

Authors:  Gizal Nakshbandi; Catharina C Moor; Esther J Nossent; J J Miranda Geelhoed; Sara J Baart; Bart G Boerrigter; Joachim G J V Aerts; Suzan F M Nijman; Helger Y Santema; Merel E Hellemons; Marlies S Wijsenbeek
Journal:  Respirology       Date:  2022-04-19       Impact factor: 6.175
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.